An outbreak of coronavirus disease 2019 (COVID-19) caused by the 2019 novel coronavirus (SARS-CoV-2) began in Wuhan, Hubei Province, China in December 2019, and has spread throughout China and to 31 other countries and territories, including the United States (1). As of February 23, 2020, there were 76,936 reported cases in mainland China and 1,875 cases in locations outside mainland China (1). There have been 2,462 associated deaths worldwide; no deaths have been reported in the United States. Fourteen cases have been diagnosed in the United States, and an additional 39 cases have occurred among repatriated persons from high-risk settings, for a current total of 53 cases within the United States. This report summarizes the aggressive measures (2,3) that CDC, state and local health departments, multiple other federal agencies, and other partners are implementing to slow and try to contain transmission of COVID-19 in the United States. These measures require the identification of cases and contacts of persons with COVID-19 in the United States and the recommended assessment, monitoring, and care of travelers arriving from areas with substantial COVID-19 transmission. Although these measures might not prevent widespread transmission of the virus in the United States, they are being implemented to 1) slow the spread of illness; 2) provide time to better prepare state and local health departments, health care systems, businesses, educational organizations, and the general public in the event that widespread transmission occurs; and 3) better characterize COVID-19 to guide public health recommendations and the development and deployment of medical countermeasures, including diagnostics, therapeutics, and vaccines. U.S. public health authorities are monitoring the situation closely, and CDC is coordinating efforts with the World Health Organization (WHO) and other global partners. Interim guidance is available at https://www.cdc.gov/coronavirus/index.html. As more is learned about this novel virus and this outbreak, CDC will rapidly incorporate new knowledge into guidance for action by CDC, state and local health departments, health care providers, and communities.
[1]
M. Biggerstaff,et al.
Novel Framework for Assessing Epidemiologic Effects of Influenza Epidemics and Pandemics
,
2013,
Emerging infectious diseases.
[2]
Stephanie Zaza,et al.
Updated preparedness and response framework for influenza pandemics.
,
2014,
MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[3]
Manish M Patel,et al.
Interim Estimates of 2019–20 Seasonal Influenza Vaccine Effectiveness — United States, February 2020
,
2020,
MMWR. Morbidity and mortality weekly report.
[4]
J. A. Navarro,et al.
Nonpharmaceutical interventions implemented by US cities during the 1918-1919 influenza pandemic.
,
2007,
JAMA.
[5]
Ting Yu,et al.
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
,
2020,
The Lancet.
[6]
M. Biggerstaff,et al.
Community Mitigation Guidelines to Prevent Pandemic Influenza — United States, 2017
,
2017,
MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[7]
M. Lipsitch,et al.
Public health interventions and epidemic intensity during the 1918 influenza pandemic
,
2007,
Proceedings of the National Academy of Sciences.